Codes / ICD10CM / H31.22

H31.22 Choroidal dystrophy (central areolar) (generalized) (peripapillary)

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Choroidal Dystrophy (Central Areolar) (Generalized) (Peripapillary) (ICD Code: H31.22)

Summary

Choroidal dystrophy (central areolar) (generalized) (peripapillary) is a group of inherited disorders affecting the choroid, the vascular layer of the eye, leading to progressive vision loss. It typically involves degeneration of the retinal cells and supportive structures, with manifestations varying by specific subtype. The condition may present as central areolar, generalized, or peripapillary patterns, each with distinct clinical features.

Causes

The condition is primarily caused by genetic mutations that are passed down through families. Specific genes involved are linked to the development and maintenance of retinal health, though the exact mechanisms may differ among subtypes. Mutations can affect proteins critical for choroidal and retinal pigment epithelium function, leading to degenerative changes over time.

Risk Factors

  • Family history of choroidal dystrophy.
  • Genetic predisposition related to known chromosomal abnormalities.

Symptoms

  • Gradual loss of central or peripheral vision, depending on subtype.
  • Decreased visual acuity.
  • Difficulties with color perception.
  • Potential night blindness in advanced stages.

Diagnosis

Diagnosis involves a comprehensive eye examination, including dilated fundus evaluation, optical coherence tomography (OCT), and genetic testing to identify specific mutations. Fluorescein angiography may also be used to assess choroidal structure and blood flow. Visual field testing and electroretinography (ERG) can help characterize functional impairment.

Treatment Options

While no cure exists, treatments aim to manage symptoms and may include:

  • Vitamin and antioxidant supplements to slow progression.
  • Low vision aids to assist with daily activities.
  • Monitoring for complications such as choroidal neovascularization.

Prognosis and Follow-Up

Prognosis varies by subtype but generally involves progressive vision loss over time. Regular follow-up with an ophthalmologist is recommended to monitor disease progression and adjust management as needed. Early detection may help preserve remaining vision.

Complications

  • Choroidal neovascularization (abnormal blood vessel growth).
  • Retinal atrophy.
  • Severe vision impairment in advanced stages.

Lifestyle & Prevention

  • Protect eyes from excessive UV exposure.
  • Maintain a balanced diet rich in antioxidants.
  • Avoid smoking, which may accelerate retinal degeneration.

When to Seek Professional Help

Seek prompt evaluation if you experience sudden changes in vision, new blind spots, or difficulty with color perception. Early intervention can help manage complications and preserve vision.

Tips for Medical Coders

When coding H31.22, ensure documentation specifies the subtype (central areolar, generalized, or peripapillary) to support accurate assignment. Include details about genetic testing, imaging findings, or family history if available to confirm the diagnosis. Avoid using this code for non-dystrophic choroidal conditions or unspecified hereditary choroidal dystrophies.

Book a walkthrough

H31.22 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.